论文部分内容阅读
目的观察初发的血糖较高的2型糖尿病患者首选胰岛素治疗的中远期临床疗效。方法对20例初发的血糖>12.0mmol/L以上的2型糖尿病患者首选胰岛素治疗,5例用连续皮下胰岛素输注,15例用常规胰岛素治疗,血糖达标后胰岛素渐减量,维持治疗2～3个月,停药后观察其疗效。结果20例患者在用胰岛素治疗后,1周左右血糖达标,2～3周后胰岛素开始减量,停药后有18例患者不再服用任何药物血糖仍能达标,最长达36个月,最短6个月,平均14个月,缓解率达90%。结论对初发的尤其是血糖较高的2型糖尿病患者首选胰岛素治疗,血糖达标快,临床缓解率高,中远期疗效好。
Objective To observe the long-term clinical efficacy of first-line insulin therapy in patients with type 2 diabetes with high blood sugar. Methods 20 patients with newly diagnosed type 2 diabetes with blood glucose> 12.0 mmol / L were given insulin treatment, 5 patients were treated with continuous subcutaneous insulin infusion, 15 patients were treated with regular insulin, the amount of insulin decreased after blood glucose reached standard, and maintenance treatment 2 ~ 3 months after stopping the observation of its efficacy. Results After treatment with insulin, 20 patients achieved blood glucose level of about 1 week. Insulin began to decrease after 2 to 3 weeks. After discontinuation of medicine, 18 patients stopped using any medicine and reached the standard of up to 36 months. The shortest 6 months, an average of 14 months, the remission rate of 90%. CONCLUSIONS: Insulin treatment is the first choice of patients with type 2 diabetes who have high blood sugar in particular. Their fasting blood glucose standard, high clinical remission rate and long-term therapeutic effect are good.